Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 22, 2019

Primary Completion Date

October 19, 2020

Study Completion Date

October 19, 2020

Conditions
Stroke, Acute
Interventions
DRUG

Trans-Sodium Crocetinate

In the study drug kit containing the experimental drug (TSC), TSC will be reconstituted with the Sterile Water for Injection (USP) supplied in the same kit. There will be an unblinded paramedic who will reconstitute and inject the TSC on the ambulance.

OTHER

Placebo

The study drug kit containing placebo (sterile saline for Injection) will be prepared and injected by the unblinded paramedic on the ambulance.

Trial Locations (2)

22908

University of Virginia, Charlottesville

90095

University of California, Los Angeles, Los Angeles

Sponsors
All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

collaborator

University of Virginia

OTHER

lead

Diffusion Pharmaceuticals Inc

INDUSTRY